Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Elife
|
July 13, 2023
Inhibitory IL-10-producing CD4<sup>+</sup> T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1
Mathew Clement, Kristin Ladell, Kelly L Miners, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
The New England Journal of Medicine
|
October 29, 2025
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026
Jake Scott, Michael S Abers, Harleen K Marwah, et al.
JAMA Internal Medicine
|
July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 1, 2025
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
JAMA
|
November 17, 2023
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial
Thomas G Stewart, Paulina A Rebolledo, Ahmad Mourad, et al.
JAMA
|
December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research Index
Linda N Geng, Kristine M Erlandson, Mady Hornig, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal for Immunotherapy of Cancer
|
October 23, 2020
Enhanced antitumor immunity through sequential targeting of PI3Kδ and LAG3
Sarah Nicol Lauder, Kathryn Smart, Veerle Kersemans, et al.
Elife
|
July 13, 2023
Inhibitory IL-10-producing CD4<sup>+</sup> T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1
Mathew Clement, Kristin Ladell, Kelly L Miners, et al.
Cell Reports
|
May 31, 2024
A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4<sup>+</sup> T cell activation
Sarah Hulin-Curtis, James K Geary, Bruce J MacLachlan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 4, 2026
Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
The New England Journal of Medicine
|
October 29, 2025
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026
Jake Scott, Michael S Abers, Harleen K Marwah, et al.
JAMA Internal Medicine
|
July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 1, 2025
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
JAMA
|
November 17, 2023
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial
Thomas G Stewart, Paulina A Rebolledo, Ahmad Mourad, et al.
JAMA
|
December 18, 2024
2024 Update of the RECOVER-Adult Long COVID Research Index
Linda N Geng, Kristine M Erlandson, Mady Hornig, et al.
Page
of 2